Related Experiment Video
Updated: Jun 14, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
General practice variation in peptic ulcer prophylaxis: a nationwide register-based study
Peter Fentz Haastrup1, Jane Møller Hansen2, Jens Søndergaard1
1Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Proton pump inhibitor (PPI) under-prescribing for peptic ulcer bleeding prophylaxis is common in Danish general practices. Few practice characteristics influenced PPI use, highlighting a need for better risk identification methods.
Area of Science:
- Gastroenterology
- Pharmacology
- General Practice
Background:
- Peptic ulcer bleeding incidence can be reduced with prophylactic proton pump inhibitors (PPIs).
- However, PPI use varies among at-risk patients, suggesting potential under-prescribing.
- The extent of this variation in general practice settings is not well understood.
Purpose of the Study:
- To analyze the proportion of high-risk patients receiving PPI prophylaxis in Danish general practices.
- To investigate associations between general practice characteristics and PPI prescribing for ulcer bleeding prevention.
Main Methods:
- Nationwide register-based cross-sectional study.
- Analysis of patients at risk of ulcer bleeding within Danish general practices.
- Logistic regression to examine practice characteristic associations with PPI treatment.
Main Results:
- Less than 40% of at-risk patients were covered by PPIs in most general practices.
- Geographical variations in PPI coverage were observed, with higher rates outside the capital.
- Older, female-dominated, and partnership practices showed higher PPI coverage compared to younger or male-dominated ones.
Conclusions:
- Significant under-prescribing of ulcer prophylaxis exists across various general practice types.
- Few practice characteristics were strongly associated with PPI prescribing patterns.
- New methods are needed to help general practitioners identify patients at risk for ulcer complications.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

